Biological Effects <strong>of</strong> -Carotene Batieha, AM; Armenian, HK; Norkus, EP; Morris, JS; Spate, VE; Comstock, GW. Serum micronutrients <strong>and</strong> the subsequent risk <strong>of</strong> cervical cancer in a population-based nested case-control study. Cancer Epidemiol. Biomark. Prev., 1993, 2, 335-339. Bendich, A; Shapiro, S. Effect <strong>of</strong> beta-carotene <strong>and</strong> canthaxanthin on the immune responses <strong>of</strong> the rat. J Nutr, 1986, 116, 2254-2262. Bendich, A; Olson, JA. Biological actions <strong>of</strong> carotenoids. FASEB J., 1989, 3, 1927-1932. Bendich, A. Carotenoids <strong>and</strong> the immune resppnse. J Nutl., 1989a, 119, 112-115 Ben-Dor, A; Steiner, M; Gheber, L; Danilenko, M; Dubi, N; Linnewiel, K; Zick, A; Sharoni, Y; Levy, J. Carotenoids activate the antioxidant response element transcription system. Mol Cancer Ther., 2005, 4, 177-186. Bjelke, E. Dietary vitamin A <strong>and</strong> human lung cancer. Int J Cancer, 1975, 15, 561-565. Bjelakovic, G; Nikolova, D; Simonetti, RG; Gluud, C. Antioxidant supplements for prevention <strong>of</strong> gastrointestinal cancers: a systematic review <strong>and</strong> meta-analysis. Lancet, 2004, 364, 1219-1228. Bjelakovic, G; Nagorni, A; Nikolova, D; Simonetti, RG; Bjelakovic, M; Gluud, C. Metaanalysis: antioxidant supplements for primary <strong>and</strong> secondary prevention <strong>of</strong> colorectal adenoma. Aliment Pharmacol Ther., 2006, 24, 281- 291. Bjelakovic, G; Nikolova, D; Gluud, LL; Simonetti, RG; Gluud, C. Mortality in R<strong>and</strong>omized Trials <strong>of</strong> Antioxidant Supplements for Primary <strong>and</strong> Secondary Prevention Systematic Review <strong>and</strong> Meta-analysis. JAMA, 2007, 297, 842-857 Bjelakovic, G; Nikolova, D; Simonetti, RG; Gluud, C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev., 2008, 16, CD004183. Bjelakovic, G; Nikolova, D; Simonetti, RG; Gluud, C. Systematic review <strong>and</strong> metaanalysis: primary <strong>and</strong> secondary prevention <strong>of</strong> gastrointestinal cancers with antioxidant supplements. Aliment Pharmacol Ther., 2008a, In Press. Black, HS. Radical interception by carotenoids <strong>and</strong> effects on UV carcinogenesis. Nutr Cancer, 1998, 31, 212-217. Black, HS; Okotie-Eboh, G; Gerguis, J. Diet potentiates the UVcarcinogenic response to beta-carotene. Nutr Cancer, 2000, 37, 173-178. Block, G. The data support a role for antioxidant in reducing cancer risk. Nutr Rev., 1992, 50, 207-211. Block, G; Patterson, B; Subar, A. Fruit, vegetables, <strong>and</strong> cancer prevention: a review <strong>of</strong> the epidemiological evidence. Nutr Cancer, 1992a, 18, 1-29. Blomh<strong>of</strong>f, R; Green; MG; Norum, KR. Vitamin A: physiological <strong>and</strong> biochemical processing. Annu Rev Nutr., 1992, 12, 37-57. Blot, WJ; Taylor, PR; Guo, W; Dawsey, S; Wang, GO; Yang, CS; Zheng, SF; Gail, M; Li, GY; Liu, BQ; Fraumeni, JF; Zhang, YH; Li, B. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, <strong>and</strong> disease specific mortality in the general population. J Natl Cancer Inst., 1993, 85, 1483-1492. Brambilla, D; Mancuso, C; Scuderi, MR; Bosco, P; Cantarella, G; Lempereur, L; Benedetto, GD; Pezzino, S; Bernardini, R. The role <strong>of</strong> antioxidant supplement in immune system, neoplastic, <strong>and</strong> neurodegenerative disorders: a point <strong>of</strong> view for an assessment <strong>of</strong> the risk/benefit pr<strong>of</strong>ile. Nutr J, 2008, 30, 29-31. 35
36 Rosa Martha Perez Gutierrez, Adriana Maria Neira Gonzalez et al. Brazionis, L; Rowley, K; Itsiopoulos, C; O'Dea, K. Plasma carotenoids <strong>and</strong> diabetic retinopathy. Br J Nutr., 2008, 13, 1-139. Burton, GW; Ingold, KU. Beta-carotene, an unusual type <strong>of</strong> lipid antioxidant. Science, 1984, 224, 569-573. Burton, GW. Antioxidant action <strong>of</strong> carotenoids. J Nutr., 1989, 119, 109-111. Byers, TE; Grahams, S; Haughey, BP; Marshall, JR; Swanson, MK. Diet <strong>and</strong> lung cancer risk: Findings from the Western New York diet stuy. Amer J Epidem, 1987, 125, 351-363 Cahill, RJ; O'Sullivan, KR; Mathias, PM; Beattie S; Hamilton, H; Morain, CO. Effect <strong>of</strong> vitamin antioxidant supplementation on cell kinetics <strong>of</strong> patients with adenomatous polyps. Gut, 1993, 34, 963-967. Cancer Research UK. Cancer statistics: bowel cancer. Available at:http://info.cancerresearchuk. org/cancerstats/types/bowel/. November 2006. Caraballoso, M; Sacristan, M; Serra, C; Bonfill, X. Drugs for preventing lung cancer in healthy people. Cochrane Database Syst Rev., 2003, 2, CD002141. doi: 10.1002/14651858.CD002141. Cardinault, N; Abalain, JH; Sairafi, B; Coudray, C; Grolier, P; Rambeau, M; Carre, JL; Mazur, A; Rock, E. Lycopene but not lutein nor zeaxanthin decreases in serum <strong>and</strong> lipopro- teins in age-related macular degeneration patients. Clin Chim Acta, 2005, 357, 34-42. Chen, X; Scholl, TO. Oxidative stress: changes in pregnancy <strong>and</strong> with gestational diabetes mellitus. Curr Diab Rep., 2005, 5, 282-288. Christen, WG; Manson, JE; Robert, M; Glynn, J; Gaziano, JM; Chew, EY; Buring, CH; Hennekens, JE. Beta carotene supplementation <strong>and</strong> age-related maculopathy in a r<strong>and</strong>omized trial <strong>of</strong> US physicians. Arch Ophthalmol, 2007, 125, 456-459. Christian, P; Schulze, K; Stoltzfus, RJ; West, KP; Jr. Hyporetinemia, illness symptoms, <strong>and</strong> acute phase protein response in pregnant women with <strong>and</strong> without night blindness. Am J Clin Nutr., 1998, 67, 123743. C<strong>of</strong>fey, RJ; Hawkey, CJ; Damstrup, L; Graves-Deal, R; Dempsey, DJ; Chinery, R; DuBois, RN; Jetton, TL; Morrow, JD. Epidermal growth factor receptor activation induces nuclear targeting <strong>of</strong> cyclooxygenase-2, basolateral release <strong>of</strong> prostagl<strong>and</strong>ins, <strong>and</strong> mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci., 1997, 94, 657-662. Collins, AR. Antioxidant intervention as a route to cancer prevention. European Journal <strong>of</strong> Cancer, 2005, 41, 1923-1930. Comstock, GW; Helzlsouer, KI. Preventive nutrition <strong>and</strong> lung cancer In: A Bendich <strong>and</strong> R.J. Deckelbaum Humana Press, 1997, 109-114 Comstock, GW; Alberg, AJ; Huang, HY; Wu, K; Burke, AE; H<strong>of</strong>fman, SC; Norkus, EP; Gross, M; Cutler, RG; Morris, JS; Spate, VL; Helzlsouer, KJ. The risk <strong>of</strong> developing lung cancer associated with antioxidants in the blood: ascorbic acids, carotenoids, alphatocopherol, selenium, <strong>and</strong> total peroxyl radical absorbing capacity. Am J Epidemiol, 2008, 168, 831-840. Cooper, DA; Eldridge, AL; Peters, JC. Dietary carotenoids <strong>and</strong> lung cancer: a review <strong>of</strong> recent research. Nutr Rev., 1999, 57, 133-145.
- Page 2 and 3: BIOTECHNOLOGY IN AGRICULTURE, INDUS
- Page 4: Industrial Biotechnology Shara L. A
- Page 7 and 8: Copyright © 2009 by Nova Science P
- Page 9 and 10: viii Contents Chapter 8 Pharmacolog
- Page 11 and 12: x Alejandro Varela and Jasiah Ibañ
- Page 13 and 14: xii Alejandro Varela and Jasiah Iba
- Page 15 and 16: xiv Alejandro Varela and Jasiah Iba
- Page 18 and 19: In: Medicinal Plants: Classificatio
- Page 20 and 21: Biological Effects of -Carotene acy
- Page 22 and 23: Biological Effects of -Carotene cry
- Page 24 and 25: Biological Effects of -Carotene ris
- Page 26 and 27: Biological Effects of -Carotene Whe
- Page 28 and 29: Biological Effects of -Carotene fla
- Page 30 and 31: Biological Effects of -Carotene Pre
- Page 32 and 33: Biological Effects of -Carotene A (
- Page 34 and 35: Biological Effects of -Carotene As
- Page 36 and 37: Biological Effects of -Carotene car
- Page 38 and 39: Biological Effects of -Carotene res
- Page 40 and 41: Biological Effects of -Carotene the
- Page 42 and 43: Biological Effects of -Carotene cat
- Page 44 and 45: Biological Effects of -Carotene mos
- Page 46 and 47: Biological Effects of -Carotene dia
- Page 48 and 49: Biological Effects of -Carotene veg
- Page 50 and 51: Biological Effects of -Carotene .Su
- Page 54 and 55: Biological Effects of -Carotene Dah
- Page 56 and 57: Biological Effects of -Carotene Hal
- Page 58 and 59: Biological Effects of -Carotene Kva
- Page 60 and 61: Biological Effects of -Carotene Osh
- Page 62 and 63: Biological Effects of -Carotene San
- Page 64: Biological Effects of -Carotene Van
- Page 67 and 68: 50 Gustavo J. Martínez, Mara Sato
- Page 69 and 70: 52 Gustavo J. Martínez, Mara Sato
- Page 71 and 72: 54 Gustavo J. Martínez, Mara Sato
- Page 73 and 74: 56 Gustavo J. Martínez, Mara Sato
- Page 75 and 76: 58 [2] Gustavo J. Martínez, Mara S
- Page 77 and 78: 60 Gustavo J. Martínez, Mara Sato
- Page 79 and 80: 62 Gustavo J. Martínez, Mara Sato
- Page 81 and 82: 64 Gustavo J. Martínez, Mara Sato
- Page 83 and 84: 66 Gustavo J. Martínez, Mara Sato
- Page 85 and 86: 68 Gustavo J. Martínez, Mara Sato
- Page 87 and 88: 70 Gustavo J. Martínez, Mara Sato
- Page 89 and 90: Huperzia saururus (Lam.) Trevis. Mi
- Page 91 and 92: 74 Gustavo J. Martínez, Mara Sato
- Page 93 and 94: 76 Gustavo J. Martínez, Mara Sato
- Page 95 and 96: PNEUMONOLOGY AND INFECTIOUS DISEASE
- Page 97 and 98: 80 Gustavo J. Martínez, Mara Sato
- Page 99 and 100: 82 Gustavo J. Martínez, Mara Sato
- Page 101 and 102: 84 Gustavo J. Martínez, Mara Sato
- Page 103 and 104:
86 Gustavo J. Martínez, Mara Sato
- Page 105 and 106:
88 Gustavo J. Martínez, Mara Sato
- Page 107 and 108:
90 Gustavo J. Martínez, Mara Sato
- Page 109 and 110:
92 Gustavo J. Martínez, Mara Sato
- Page 111 and 112:
94 Gustavo J. Martínez, Mara Sato
- Page 113 and 114:
96 Gustavo J. Martínez, Mara Sato
- Page 115 and 116:
98 Aracely E. Chávez-Piña and And
- Page 117 and 118:
100 Aracely E. Chávez-Piña and An
- Page 119 and 120:
102 Aracely E. Chávez-Piña and An
- Page 121 and 122:
104 Aracely E. Chávez-Piña and An
- Page 123 and 124:
106 Aracely E. Chávez-Piña and An
- Page 125 and 126:
108 Aracely E. Chávez-Piña and An
- Page 127 and 128:
110 Aracely E. Chávez-Piña and An
- Page 129 and 130:
112 Aracely E. Chávez-Piña and An
- Page 131 and 132:
114 Aracely E. Chávez-Piña and An
- Page 133 and 134:
116 Aracely E. Chávez-Piña and An
- Page 135 and 136:
118 HO HO HO HO HO HO OH OH M e Me
- Page 137 and 138:
120 Me Me OH Me O OH O O OH H Me OH
- Page 139 and 140:
122 HO HO HO Aracely E. Chávez-Pi
- Page 141 and 142:
124 Aracely E. Chávez-Piña and An
- Page 143 and 144:
126 Aracely E. Chávez-Piña and An
- Page 145 and 146:
128 Aracely E. Chávez-Piña and An
- Page 147 and 148:
130 Aracely E. Chávez-Piña and An
- Page 149 and 150:
132 Aracely E. Chávez-Piña and An
- Page 151 and 152:
134 Aracely E. Chávez-Piña and An
- Page 153 and 154:
136 Aracely E. Chávez-Piña and An
- Page 155 and 156:
138 Aracely E. Chávez-Piña and An
- Page 157 and 158:
140 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 159 and 160:
142 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 161 and 162:
144 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 163 and 164:
146 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 165 and 166:
148 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 167 and 168:
150 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 169 and 170:
152 6.4. Antibacterial Effects Hua-
- Page 171 and 172:
154 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 173 and 174:
156 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 175 and 176:
158 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 177 and 178:
160 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 179 and 180:
162 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 181 and 182:
164 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 183 and 184:
166 Hua-Bin Li, Dan Li, Ren-You Gan
- Page 185 and 186:
168 Vandana Gulati, Ian H. Harding
- Page 187 and 188:
170 Vandana Gulati, Ian H. Harding
- Page 189 and 190:
172 Vandana Gulati, Ian H. Harding
- Page 191 and 192:
174 Vandana Gulati, Ian H. Harding
- Page 193 and 194:
176 Vandana Gulati, Ian H. Harding
- Page 195 and 196:
178 Vandana Gulati, Ian H. Harding
- Page 197 and 198:
180 Vandana Gulati, Ian H. Harding
- Page 199 and 200:
182 Vandana Gulati, Ian H. Harding
- Page 201 and 202:
184 Vandana Gulati, Ian H. Harding
- Page 203 and 204:
186 Vandana Gulati, Ian H. Harding
- Page 206 and 207:
In: Medicinal Plants: Classificatio
- Page 208 and 209:
Biomolecules with Anti-Mycobacteria
- Page 210 and 211:
Biomolecules with Anti-Mycobacteria
- Page 212 and 213:
Biomolecules with Anti-Mycobacteria
- Page 214 and 215:
Biomolecules with Anti-Mycobacteria
- Page 216 and 217:
Biomolecules with Anti-Mycobacteria
- Page 218:
Biomolecules with Anti-Mycobacteria
- Page 221 and 222:
204 Chien-Yi Chen Ligusticum chuanx
- Page 223 and 224:
206 Chien-Yi Chen (IAEA 336), also
- Page 225 and 226:
208 Chien-Yi Chen 4. Results and Di
- Page 227 and 228:
210 4.3. Fresh Leaves and Stems Chi
- Page 229 and 230:
212 Chien-Yi Chen collected from na
- Page 231 and 232:
214 Chien-Yi Chen primary enzyme in
- Page 233 and 234:
216 Chien-Yi Chen [20] Liu SM, Chun
- Page 235 and 236:
218 S.M.M. Vasconcelos, J.E.R. Hon
- Page 237 and 238:
220 S.M.M. Vasconcelos, J.E.R. Hon
- Page 239 and 240:
222 S.M.M. Vasconcelos, J.E.R. Hon
- Page 241 and 242:
224 S.M.M. Vasconcelos, J.E.R. Hon
- Page 243 and 244:
226 S.M.M. Vasconcelos, J.E.R. Hon
- Page 245 and 246:
228 S.M.M. Vasconcelos, J.E.R. Hon
- Page 247 and 248:
230 S.M.M. Vasconcelos, J.E.R. Hon
- Page 249 and 250:
232 S.M.M. Vasconcelos, J.E.R. Hon
- Page 251 and 252:
234 S.M.M. Vasconcelos, J.E.R. Hon
- Page 253 and 254:
236 S.M.M. Vasconcelos, J.E.R. Hon
- Page 255 and 256:
238 S.M.M. Vasconcelos, J.E.R. Hon
- Page 257 and 258:
240 S.M.M. Vasconcelos, J.E.R. Hon
- Page 259 and 260:
242 S.M.M. Vasconcelos, J.E.R. Hon
- Page 261 and 262:
244 Sônia Sin Singer Brugiolo, Luc
- Page 263 and 264:
246 Sônia Sin Singer Brugiolo, Luc
- Page 265 and 266:
248 Sônia Sin Singer Brugiolo, Luc
- Page 267 and 268:
250 Sônia Sin Singer Brugiolo, Luc
- Page 269 and 270:
252 Sônia Sin Singer Brugiolo, Luc
- Page 271 and 272:
254 Sônia Sin Singer Brugiolo, Luc
- Page 273 and 274:
256 C.W. Huck and G.K. Bonn Keyword
- Page 275 and 276:
258 C.W. Huck and G.K. Bonn No addi
- Page 277 and 278:
260 C.W. Huck and G.K. Bonn The rob
- Page 279 and 280:
262 C.W. Huck and G.K. Bonn Validat
- Page 281 and 282:
264 Naphthodianthrones C.W. Huck an
- Page 283 and 284:
266 C.W. Huck and G.K. Bonn Figure
- Page 285 and 286:
268 C.W. Huck and G.K. Bonn Figure
- Page 287 and 288:
270 C.W. Huck and G.K. Bonn hierarc
- Page 289 and 290:
272 C.W. Huck and G.K. Bonn [17] Hu
- Page 292 and 293:
In: Medicinal Plants Classification
- Page 294 and 295:
What is the Future of Phytotherapy?
- Page 296 and 297:
In: Medicinal Plants Classification
- Page 298 and 299:
Quality Control of Polysaccharides
- Page 300 and 301:
Quality Control of Polysaccharides
- Page 302 and 303:
Quality Control of Polysaccharides
- Page 304 and 305:
Quality Control of Polysaccharides
- Page 306 and 307:
Quality Control of Polysaccharides
- Page 308 and 309:
Quality Control of Polysaccharides
- Page 310 and 311:
Quality Control of Polysaccharides
- Page 312 and 313:
Origins Targets Neisseria meningiti
- Page 314 and 315:
Quality Control of Polysaccharides
- Page 316 and 317:
Quality Control of Polysaccharides
- Page 318 and 319:
Quality Control of Polysaccharides
- Page 320 and 321:
Quality Control of Polysaccharides
- Page 322 and 323:
Quality Control of Polysaccharides
- Page 324 and 325:
Quality Control of Polysaccharides
- Page 326 and 327:
Quality Control of Polysaccharides
- Page 328 and 329:
Quality Control of Polysaccharides
- Page 330:
Quality Control of Polysaccharides
- Page 333 and 334:
316 Philippe N. Okusa, Caroline Ste
- Page 335 and 336:
318 Philippe N. Okusa, Caroline Ste
- Page 337 and 338:
320 2.7. General Toxicity Tests Phi
- Page 339 and 340:
322 Philippe N. Okusa, Caroline Ste
- Page 341 and 342:
324 Philippe N. Okusa, Caroline Ste
- Page 343 and 344:
326 Philippe N. Okusa, Caroline Ste
- Page 345 and 346:
328 Philippe N. Okusa, Caroline Ste
- Page 347 and 348:
330 Philippe N. Okusa, Caroline Ste
- Page 349 and 350:
332 Philippe N. Okusa, Caroline Ste
- Page 351 and 352:
334 Philippe N. Okusa, Caroline Ste
- Page 353 and 354:
336 Philippe N. Okusa, Caroline Ste
- Page 355 and 356:
338 age-related macular degeneratio
- Page 357 and 358:
340 B lymphocytes, 7 babies, 60, 62
- Page 359 and 360:
342 cell surface, 229 cellular adhe
- Page 361 and 362:
344 cultivation, 75, 76, 83, 85, 14
- Page 363 and 364:
346 embryonic stem cells, 47 emotio
- Page 365 and 366:
348 gas, xiii, 21, 104, 131, 145, 1
- Page 367 and 368:
350 high-performance liquid chromat
- Page 369 and 370:
352 institutions, 84 instruments, 2
- Page 371 and 372:
354 lung, ix, 1, 6, 16, 17, 22, 23,
- Page 373 and 374:
356 mucosa, x, 2, 19, 97, 98, 99, 1
- Page 375 and 376:
358 oxidative, 4, 8, 9, 10, 12, 13,
- Page 377 and 378:
360 polyunsaturated fatty acids, 10
- Page 379 and 380:
362 Reserpine, 328 reservation, 143
- Page 381 and 382:
364 SPT, 135 squamous cell carcinom
- Page 383 and 384:
366 transcription, 8, 35, 152 trans